靶向铁死亡和铁自噬: 心血管疾病的新靶点? DOI
Yi Luan, Yang Yang, Ying Luan

et al.

Journal of Zhejiang University SCIENCE B, Journal Year: 2024, Volume and Issue: 25(1), P. 1 - 22

Published: Jan. 1, 2024

Language: Английский

Overcoming cancer chemotherapy resistance by the induction of ferroptosis DOI
Yumin Wang,

Xiaorui Wu,

Ren Zhao

et al.

Drug Resistance Updates, Journal Year: 2022, Volume and Issue: 66, P. 100916 - 100916

Published: Dec. 29, 2022

Language: Английский

Citations

168

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes DOI Creative Commons
Yumin Wang, Shuang Wu, Qiang Li

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(24)

Published: June 21, 2023

Emerging evidence suggests that ferroptosis, a unique regulated cell death modality is morphologically and mechanistically different from other forms of death, plays vital role in the pathophysiological process neurodegenerative diseases, strokes. Accumulating supports ferroptosis as critical factor diseases strokes, pharmacological inhibition therapeutic target for these diseases. In this review article, core mechanisms are overviewed roles strokes described. Finally, emerging findings treating through This demonstrates by bioactive small-molecule compounds (ferroptosis inhibitors) could be effective treatments highlights potential promising avenue used to prevent article will shed light on developing novel regimens slow down progression future.

Language: Английский

Citations

86

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases DOI Creative Commons
Yumin Wang, Jing Hu, Shuang Wu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Dec. 10, 2023

Abstract Ferroptosis, a unique modality of cell death with mechanistic and morphological differences from other modes, plays pivotal role in regulating tumorigenesis offers new opportunity for modulating anticancer drug resistance. Aberrant epigenetic modifications posttranslational (PTMs) promote resistance, cancer progression, metastasis. Accumulating studies indicate that can transcriptionally translationally determine vulnerability to ferroptosis functions as driver nervous system diseases (NSDs), cardiovascular (CVDs), liver diseases, lung kidney diseases. In this review, we first summarize the core molecular mechanisms ferroptosis. Then, roles processes, including histone PTMs, DNA methylation, noncoding RNA regulation such phosphorylation, ubiquitination, SUMOylation, acetylation, ADP-ribosylation, are concisely discussed. The PTMs genesis cancers, NSD, CVDs, well application PTM modulators therapy these then discussed detail. Elucidating mediated by will facilitate development promising combination therapeutic regimens containing or PTM-targeting agents inducers be used overcome chemotherapeutic resistance could prevent addition, highlight potential approaches chemoresistance halt

Language: Английский

Citations

77

Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases DOI Creative Commons
Qi Feng, Yang Yang, Kaidi Ren

et al.

International Journal of Biological Sciences, Journal Year: 2023, Volume and Issue: 19(12), P. 3726 - 3743

Published: Jan. 1, 2023

Ferroptosis is an iron-dependent programmed cell death pattern that characterized by iron overload, reactive oxygen species (ROS) accumulation and lipid peroxidation. Growing viewpoints support the imbalance of homeostasis disturbance metabolism contribute to tissue or organ injury in various kidney diseases triggering ferroptosis. At present, key regulators complicated network mechanisms associated with ferroptosis have been deeply studied; however, its role initiation progression has not fully revealed. Herein, we aim discuss features, ferroptosis, explore emerging roles organelles gather pharmacological progress, systematically summarize most recent discoveries about crosstalk between diseases, including renal carcinoma (RCC), acute (AKI), diabetic disease (DKD), autosomal dominant polycystic (ADPKD), fibrosis, lupus nephritis (LN) IgA nephropathy. We further conclude potential therapeutic strategies targeting for prevention treatment hope this work will provide insight study pathogenesis kidney-related diseases.

Language: Английский

Citations

36

Role of Autophagy Pathway in Parkinson’s Disease and Related Genetic Neurological Disorders DOI Creative Commons
Christos Themistokleous, Enrico Bagnoli, Ramaa Parulekar

et al.

Journal of Molecular Biology, Journal Year: 2023, Volume and Issue: 435(12), P. 168144 - 168144

Published: May 13, 2023

The elucidation of the function PINK1 protein kinase and Parkin ubiquitin E3 ligase in elimination damaged mitochondria by autophagy (mitophagy) has provided unprecedented understanding mechanistic pathways underlying Parkinson's disease (PD). We provide a comprehensive overview general importance related disorders central nervous system. This reveals critical link between neurodegenerative neurodevelopmental suggests that strategies to modulate mitophagy may have greater relevance CNS beyond PD.

Language: Английский

Citations

29

Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases DOI Creative Commons
Jinghan Li,

Sujuan Zheng,

Yumei Fan

et al.

Cell Death and Disease, Journal Year: 2023, Volume and Issue: 14(9)

Published: Sept. 22, 2023

Abstract Kidney diseases remain one of the leading causes human death and have placed a heavy burden on medical system. Regulated cell contributes to pathology plethora renal diseases. Recently, with in-depth studies into kidney death, new iron-dependent modality, known as ferroptosis, has been identified attracted considerable attention among researchers in pathogenesis therapeutics treat them. The majority suggest that ferroptosis plays an important role pathologies multiple diseases, such acute injury (AKI), chronic disease, carcinoma. In this review, we summarize recently regulatory molecular mechanisms discuss pathways action various describe protective effect inhibitors against especially AKI. By summarizing prominent roles different progress made studying provide directions strategies for future research summary, ferroptotic factors are potential targets therapeutic intervention alleviate targeting them may lead treatments patients

Language: Английский

Citations

28

SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma DOI Creative Commons

Zi‐Wen Duan,

Wei‐Ting Wang,

Yan Wang

et al.

Clinical and Translational Medicine, Journal Year: 2025, Volume and Issue: 15(3)

Published: March 1, 2025

Language: Английский

Citations

1

Ferroptosis and Alzheimer’s: unveiling new avenues for the treatment and prevention DOI
Veerta Sharma,

Prateek Sharma,

Thakur Gurjeet Singh

et al.

Metabolic Brain Disease, Journal Year: 2025, Volume and Issue: 40(4)

Published: April 1, 2025

Language: Английский

Citations

1

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy DOI Creative Commons
Huiyan Sun, Dandan Chen,

Wenjing Xin

et al.

Frontiers in Pharmacology, Journal Year: 2023, Volume and Issue: 14

Published: April 13, 2023

Cardiomyopathies are a clinically heterogeneous group of cardiac diseases characterized by heart muscle damage, resulting in myocardium disorders, diminished function, failure, and even sudden death. The molecular mechanisms underlying the damage to cardiomyocytes remain unclear. Emerging studies have demonstrated that ferroptosis, an iron-dependent non-apoptotic regulated form cell death iron dyshomeostasis lipid peroxidation, contributes development ischemic cardiomyopathy, diabetic doxorubicin-induced septic cardiomyopathy. Numerous compounds exerted potential therapeutic effects on cardiomyopathies inhibiting ferroptosis. In this review, we summarize core mechanism which ferroptosis leads these cardiomyopathies. We emphasize emerging types can inhibit delineate their beneficial treating This review suggests pharmacologically may be strategy for cardiomyopathy treatment.

Language: Английский

Citations

18

The PTBP1‑NCOA4 axis promotes ferroptosis in liver cancer cells DOI Creative Commons
Hao Yang,

Wensheng Sun,

Tao Bi

et al.

Oncology Reports, Journal Year: 2023, Volume and Issue: 49(2)

Published: Jan. 13, 2023

Polypyrimidine tract‑binding protein 1 (PTBP1) plays an important role in tumor immunity, cell proliferation, apoptosis, and autophagy by regulating RNA metabolism. However, the specific function mechanism of PTBP1 ferroptosis remain unclear. In present study, it was investigated whether regulates exact mechanism. The iron, malondialdehyde (MDA), GSH levels were detected sorafenib (SF)‑treated liver cancer cells. si‑PTBP1 introduction into SF‑treated cells resulted a significant reduction MDA iron. Additionally, recovery observed after silencing PTBP1. StarBase v2.0 database used to predict potential transcripts that can physically interact with nuclear receptor coactivator 4 (NCOA4) mRNA identified as most enriched binding partner PTBP1‑RNA complex. A dual‑luciferase assay then demonstrated directly interacted NCOA4. did not affect NCOA4 stability following treatment cycloheximide. pull‑down revealed PTBP1‑binding region 5'‑UTR sequence. These results suggest mediates translation. vivo experiments reconfirmed PTBP1‑NCOA4 axis xenograft transplantation model. It mean weight increased knockout. conclusion, decreased sensitivity SF regulated ferritinophagy mediating

Language: Английский

Citations

17